| Literature DB >> 28416276 |
Adolfo Amici1, Ambra A Grolla2, Erika Del Grosso2, Roberta Bellini2, Michele Bianchi2, Cristina Travelli2, Silvia Garavaglia2, Leonardo Sorci1, Nadia Raffaelli3, Silverio Ruggieri3, Armando A Genazzani4, Giuseppe Orsomando5.
Abstract
Adenosine 5'-tetraphosphate (Ap4) is a ubiquitous metabolite involved in cell signaling in mammals. Its full physiological significance remains unknown. Here we show that two enzymes committed to NAD biosynthesis, nicotinamide phosphoribosyltransferase (NAMPT) and nicotinate phosphoribosyltransferase (NAPT), can both catalyze the synthesis and degradation of Ap4 through their facultative ATPase activity. We propose a mechanism for this unforeseen additional reaction, and demonstrate its evolutionary conservation in bacterial orthologs of mammalian NAMPT and NAPT. Furthermore, evolutionary distant forms of NAMPT were inhibited in vitro by the FK866 drug but, remarkably, it does not block synthesis of Ap4. In fact, FK866-treated murine cells showed decreased NAD but increased Ap4 levels. Finally, murine cells and plasma with engineered or naturally fluctuating NAMPT levels showed matching Ap4 fluctuations. These results suggest a role of Ap4 in the actions of NAMPT, and prompt to evaluate the role of Ap4 production in the actions of NAMPT inhibitors.Entities:
Keywords: ATPase; Ap4; B16 cells; FK866; NAMPT; NAPT; NadV; PncB; mouse plasma; type II phosphoribosyltransferases
Mesh:
Substances:
Year: 2017 PMID: 28416276 DOI: 10.1016/j.chembiol.2017.03.010
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116